ARCHIVES

FDA Designates Zometa For Priority Review.

This article is from The Cancer Letter archive.

Vol. 27 No. 44 | November 30, 2001

Download PDF Visit The Full Archive

Related Articles

ASCO And ESMO Publish Training Recommendations

November 26, 2004

NCI Facing Extended Tie Under Acting Director – Maybe

August 19, 1988

Personal letters: mixed reviews of Donald Pinkel’s article on Childhood Lymphocytic Leukemia

May 6, 2021

Pryce Introduces Bill To Reimbuse For Orally Administered Cancer Drugs.

May 4, 2001

Winship to Open Glenn Family Breast Center

February 7, 2013

In Brief: Shubik, Rhoads, Dixon Affiliations With Industry Lister By House Subcommittee

June 11, 1976